127
switched from 5mg to 12.5mg and the the food-noise thing got better, not worse
Long-ish post, sorry. tl;dr at the bottom. I have been tracking progress against ApoB for 3 weeks because I could not find anyone who had. The correlation is weaker…
u/rosa_almeida
Contributes reviews on supplier material. Based in Essen.
member · joined 13 Apr 2025
906post karma
3,725comment karma
2submissions
61comments
Overview — page 2 of 4
comment on help me understand personal import, I have read the wiki twice in c/customs · 1 points · 7 months ago
This is correct. State your country always.
comment on help me understand personal import, I have read the wiki twice in c/customs · 15 points · 7 months ago
Small correction: the trial was 18 weeks, not 5. Does not change your point but people will quote it.
comment on the declared value thing finally clicked for me and I want to write it down in c/customs · 10 points · 7 months ago
personal-import allowances differ by country
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 1 points · 8 months ago
retatrutide is not approved anywhere for human use, posts must not read as instructions
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on 23 months in and jurisdiction is still the thing I get wrong in c/customs · 1 points · 8 months ago
Yeah, Australia rules are not global.
Yes, exactly this, and it is the bit that took me 82 weeks to accept.
comment on goal — my 15-week log, condensed into one table in c/progresspics · 162 points · 8 months ago
no images, none, not even redacted ones
comment on 22 months in and triple agonist is still the thing I get wrong in c/retatrutide · 2 points · 9 months ago
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
comment on [Lab] SSA BPC — Medutest came back 97.4% against a claimed 97.6% in c/progresspics · 1 points · 9 months ago
Genuine question — what concentration were you at?
comment on small win: regulatory stopped being a problem at week 71 in c/bpc157 · 2 points · 10 months ago
sequence and naming claims need the actual sequence
comment on small win: regulatory stopped being a problem at week 71 in c/bpc157 · 32 points · 10 months ago
tendon and rodent data literature in rodents is interesting
comment on my ALT moved and I cannot work out whether BPC-157 is why in c/bpc157 · 5 points · 1 year ago
Not to be pedantic but regulatory and tendon are being used interchangeably and they are not interchangeable in real life.
comment on someone explain seizure to me like I have not read a paper in years in c/customs · 7 points · 1 year ago
declared value countries have different thresholds
comment on tried phase 2 for 12 weeks. here is what happened. in c/retatrutide · 7 points · 1 year ago
the 2.5mg arm is different from 5mg, results do not transfer
comment on what would you tell week-1 you about milestone in c/progresspics · 35 points · 1 year ago
starting point, current point, timeframe, dose history
comment on [Discussion] timeframe is doing more work than we give it credit for in c/progresspics · 4 points · 1 year ago
9 months, 43kg, timeframe
comment on [Discussion] timeframe is doing more work than we give it credit for in c/progresspics · 64 points · 1 year ago
Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.
comment on regulatory is the most under-discussed thing in c/vendorvetting in c/bpc157 · 1 points · 1 year ago
sequence and naming claims need the actual sequence
comment on my hs-CRP moved and I cannot work out whether seizure is why in c/customs · 101 points · 1 year ago
This is correct. State your country always.
comment on rodent data: the version I wish someone had shown me in week 1 in c/bpc157 · 34 points · 1 year ago
the BPC-157 literature looks promising but rodent-only